Literature DB >> 18386134

Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity.

Linda Hughes1, Catherine Malone, Saranya Chumsri, Angelika M Burger, Susan McDonnell.   

Abstract

The process of tumour invasion and subsequent metastasis represents the most lethal aspect of cancer. In this study the invasive and migratory activity of four human breast cancer cell lines; MCF-7, MDA-MB-231, BT474 and Hs578T was investigated. Isogenic subclones were isolated from the Hs578T cell line using sequential passages through the BD Matrigel Invasion Chamber assay system. A new invasive subclone designated, Hs578Ts(i)8 was isolated and shown to be 3-fold more invasive and 2.5-fold more migratory than the parental cell line. The variant cells formed up to 25 times more colonies in soft agar and also produced tumours in vivo in nude mice. Flow cytometry analysis showed that the Hs578Ts(i)8 cells had 30% more CD44+/CD24-/low cells than the parental Hs578T cell line. The presence of a breast cancer stem cell population within the variant cell line may provide an explanation for the increased anchorage independent growth and tumourigenicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18386134     DOI: 10.1007/s10585-008-9169-z

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  40 in total

Review 1.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

2.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

3.  Breast tumor cell lines from pleural effusions.

Authors:  R Cailleau; R Young; M Olivé; W J Reeves
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

4.  Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway.

Authors:  Kenneth Rogulski; Youjun Li; Kristi Rothermund; Lixia Pu; Simon Watkins; Fenghua Yi; Edward V Prochownik
Journal:  Oncogene       Date:  2005-11-17       Impact factor: 9.867

5.  Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines.

Authors:  A J Hackett; H S Smith; E L Springer; R B Owens; W A Nelson-Rees; J L Riggs; M B Gardner
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

6.  The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.

Authors:  P J Coopman; M T Do; M Barth; E T Bowden; A J Hayes; E Basyuk; J K Blancato; P R Vezza; S W McLeskey; P H Mangeat; S C Mueller
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

7.  Selection of more aggressive variants of the gI101A human breast cancer cell line: a model for analyzing the metastatic phenotype of breast cancer.

Authors:  Dina Chelouche Lev; Galina Kiriakova; Janet E Price
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

8.  Carboxymethyl benzylamide dextran blocks angiogenesis of MDA-MB435 breast carcinoma xenografted in fat pad and its lung metastases in nude mice.

Authors:  R Bagheri-Yarmand; Y Kourbali; A M Rath; R Vassy; A Martin; J Jozefonvicz; C Soria; H Lu; M Crépin
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

9.  Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?

Authors:  P Boyle; A d'Onofrio; P Maisonneuve; G Severi; C Robertson; M Tubiana; U Veronesi
Journal:  Ann Oncol       Date:  2003-08       Impact factor: 32.976

10.  CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.

Authors:  L Y Bourguignon; Z Gunja-Smith; N Iida; H B Zhu; L J Young; W J Muller; R D Cardiff
Journal:  J Cell Physiol       Date:  1998-07       Impact factor: 6.384

View more
  30 in total

1.  In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivo.

Authors:  Ashley J Parks; Michael P Pollastri; Mark E Hahn; Elizabeth A Stanford; Olga Novikov; Diana G Franks; Sarah E Haigh; Supraja Narasimhan; Trent D Ashton; Timothy G Hopper; Dmytro Kozakov; Dimitri Beglov; Sandor Vajda; Jennifer J Schlezinger; David H Sherr
Journal:  Mol Pharmacol       Date:  2014-08-26       Impact factor: 4.436

2.  Inhibitory effects of ethacrynic acid analogues lacking the α,β-unsaturated carbonyl unit and para-acylated phenols on human cancer cells.

Authors:  Zack E Bryant; Romy F J Janser; Medina Jabarkhail; Melissa S Candelaria-Lyons; Brittni B Romero; Severine Van slambrouck; Wim F A Steelant; Ingo Janser
Journal:  Bioorg Med Chem Lett       Date:  2010-12-19       Impact factor: 2.823

3.  The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.

Authors:  Alexandra Giatromanolaki; Efthimios Sivridis; Aliki Fiska; Michael I Koukourakis
Journal:  Med Oncol       Date:  2010-04-20       Impact factor: 3.064

4.  Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells.

Authors:  Elizabeth Tarasewicz; Lisbi Rivas; Randala Hamdan; Danijela Dokic; Vamsi Parimi; Beatriz Penalver Bernabe; Alexandra Thomas; Lonnie D Shea; Jacqueline S Jeruss
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling.

Authors:  T Nakanishi; S Chumsri; N Khakpour; A H Brodie; B Leyland-Jones; A W Hamburger; D D Ross; A M Burger
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

6.  Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro.

Authors:  Fiona Lanigan; Gabriela Gremel; Rowena Hughes; Donal J Brennan; Finian Martin; Karin Jirström; William M Gallagher
Journal:  Breast Cancer Res       Date:  2010-08-03       Impact factor: 6.466

7.  Dehydroepiandrosterone inhibits events related with the metastatic process in breast tumor cell lines.

Authors:  Rebeca López-Marure; Estrella Zapata-Gómez; Leticia Rocha-Zavaleta; María Cecilia Aguilar; Magali Espinosa Castilla; Jorge Meléndez Zajgla; Noemí Meraz-Cruz; Claudia Huesca-Gómez; Ricardo Gamboa-Ávila; Erika Olivia Gómez-González
Journal:  Cancer Biol Ther       Date:  2016-06-03       Impact factor: 4.742

8.  Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines.

Authors:  Aisling Pierce; Patricia M McGowan; Maura Cotter; Maeve Mullooly; Norma O'Donovan; Sweta Rani; Lorraine O'Driscoll; John Crown; Michael J Duffy
Journal:  Cancer Biol Ther       Date:  2013-06       Impact factor: 4.742

9.  Establishment and characterization of a new feline mammary cancer cell line, FkMTp.

Authors:  Ana Borges; Filomena Adega; Raquel Chaves
Journal:  Cytotechnology       Date:  2016-02-17       Impact factor: 2.058

10.  Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines.

Authors:  Matthew J Meyer; Jodie M Fleming; Mustapha A Ali; Mitchell W Pesesky; Erika Ginsburg; Barbara K Vonderhaar
Journal:  Breast Cancer Res       Date:  2009-11-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.